11/16/2015 - 11:38am

Mylan has launched two generics — one for diabetes and another for HIV — following final Food and Drug Administration approval. 

11/13/2015 - 3:18pm
The drug was granted Fast Track, Breakthrough, Priority Review and Accelerated Approval status by the FDA and has shown an objective response rate of 59% with a median duration of about 12.4 months. 
11/13/2015 - 3:15pm

The SugarCube device communicates directly with The SugarCube App to track, store and analyze a user's diet, exercise, glucose levels and insulin administered.

11/12/2015 - 12:55pm

At “Operation Immunization,” students screened seniors in East Harlem to ensure they could receive vaccines that were then administered by registered pharmacists.

11/12/2015 - 10:00am
The new formula for Zicam Nasal Swab is homeopathic, zinc-free and provides cooling menthol and eucalyptus to help soothe the nasal passages upon application.


11/11/2015 - 2:16pm

The drug is indicated to treat and prevent low levels of potassium (hypokalemia). 

11/11/2015 - 11:13am

Birth rates are on the rise, according to the latest report from the Centers for Disease Control and Prevention. That’s good news for sellers of family planning test kits — overall sales of both pregnancy and ovulation test kits were up 2.2% to $364.8 million across total U.S. multi-outlets for the 52 weeks ended Sept. 6, according to IRI.

11/11/2015 - 11:13am

A new, dynamic diabetes-centric set co-created by Johnson & Johnson and Wakefern has the potential to generate $1,000 in incremental dollars for every new diabetes customer captured by Wakerfern’s ShopRite stores, the companies revealed recently at the GMDC Health Beauty Wellness 2015 conference in Phoenix.

11/11/2015 - 11:13am

Valeant Pharmaceuticals’ decision to raise the prices on a handful of drugs it has acquired over the past few years has led federal lawmakers and the Department of Justice to demand that the company explain its pricing policy.